HOFSETH BIOCARE AS NOK0.01HOFSETH BIOCARE AS NOK0.01HOFSETH BIOCARE AS NOK0.01

HOFSETH BIOCARE AS NOK0.01

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪825.72 M‬NOK
−0.27NOK
‪−106.68 M‬NOK
‪190.82 M‬NOK
‪180.21 M‬
Beta (1Y)
0.46

About HOFSETH BIOCARE AS

Headquarters
Ålesund
Employees (FY)
65
Founded
2009
ISIN
NO0010598683
FIGI
BBG00JHW3452
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. Its products include ProGo Bioactive Peptides, OmeGo Salmon Oil, CalGo Calcium Collagen Complex, and Shop Branded Products. The company was founded by Roger Hofseth in 2000 and is headquartered in Alesund, Norway.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0Q6H is 2.16 NOK — it has decreased by 28.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HOFSETH BIOCARE AS NOK0.01 stocks are traded under the ticker 0Q6H.
HOFSETH BIOCARE AS NOK0.01 is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
0Q6H stock is 39.59% volatile and has beta coefficient of 0.46. Check out the list of the most volatile stocks — is HOFSETH BIOCARE AS NOK0.01 there?
Yes, you can track HOFSETH BIOCARE AS NOK0.01 financials in yearly and quarterly reports right on TradingView.
0Q6H net income for the last quarter is ‪−51.89 M‬ NOK, while the quarter before that showed ‪−22.72 M‬ NOK of net income which accounts for −128.46% change. Track more HOFSETH BIOCARE AS NOK0.01 financial stats to get the full picture.
Today HOFSETH BIOCARE AS NOK0.01 has the market capitalization of ‪825.72 M‬, it has decreased by 5.26% over the last week.
No, 0Q6H doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0Q6H shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HOFSETH BIOCARE AS NOK0.01 stock right from TradingView charts — choose your broker and connect to your account.
0Q6H reached its all-time high on Dec 9, 2020 with the price of 9.24 NOK, and its all-time low was 1.72 NOK and was reached on Feb 23, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 30, 2024, the company has 65.00 employees. See our rating of the largest employees — is HOFSETH BIOCARE AS NOK0.01 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HOFSETH BIOCARE AS NOK0.01 technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HOFSETH BIOCARE AS NOK0.01 stock shows the sell signal. See more of HOFSETH BIOCARE AS NOK0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HOFSETH BIOCARE AS NOK0.01 EBITDA is ‪−90.75 M‬ NOK, and current EBITDA margin is −52.39%. See more stats in HOFSETH BIOCARE AS NOK0.01 financial statements.